A carregar...
CGRP monoclonal antibody for preventive treatment of chronic migraine: An update of meta‐analysis
BACKGROUND: CGRP monoclonal antibody (mAb) is a promising preventive treatment for episodic migraine and has been approved by US FDA recently. But the treatments for chronic migraine are rare. Therefore, we performed meta‐analysis to assess the efficacy and safety of CGRP mAbs in preventing chronic...
Na minha lista:
| Publicado no: | Brain Behav |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6379644/ https://ncbi.nlm.nih.gov/pubmed/30656853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1215 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|